Meg Anderson
About Meg Anderson
Current Role at Bristol Myers Squibb
Meg Anderson currently holds the position of Vice President, US Zeposia Brand Lead at Bristol Myers Squibb in Princeton, New Jersey. In this role, she is responsible for leading the strategic marketing and commercialization of Zeposia in the US market. Her expertise in brand management and medical strategy is crucial to the success of Zeposia, a key product in the company's portfolio.
Previous Experience at Bristol Myers Squibb
Before her current role, Meg Anderson served as Vice President, WW Commercial, Zeposia Brand Head for seven months in 2021 at Bristol Myers Squibb. During this period, she played a pivotal role in global brand strategy and commercialization efforts for Zeposia. Her work in this position laid the groundwork for her current responsibilities.
Career at Johnson & Johnson
Meg Anderson has an extensive career at Johnson & Johnson spanning several roles. She served as Sr. Director of Marketing, Biosurgery and Strategic Growth Segments from 2019 to 2021, and as Senior Director of Marketing, Specialty, Ethicon Inc., from 2018 to 2019. Additionally, she held positions as Director of Marketing for Janssen Infectious Diseases, Regional Business Director of Dermatology at Janssen Immunology, Group Product Director of Dermatology Marketing at Janssen Immunology, and Group Product Director of Chronic Care at Janssen Oncology. Her diverse roles have equipped her with extensive experience in both pharmaceutical and medical device sectors.
Educational Background
Meg Anderson holds a Bachelor of Arts in English from the University of Iowa, where she studied from 1991 to 1996. This strong foundation in communication and analytical skills has been instrumental in her successful career in marketing and brand management within the healthcare industry.
Expertise and Skills
Meg Anderson possesses extensive experience in strategic marketing, financial acumen, and strategic alliance management. She has successfully led multidisciplinary business teams to achieve commercial success, with a focus on advancing talent and business to impact bottom-line profitability. Her career highlights include leading the launch of Zeposia in the US market and a proven track record in both pharmaceutical and medical device sectors.